A Lyme disease vaccine is finally in the works, and Pfizer is taking the lead in developing the biological preparation. The New York City-headquartered pharmaceutical company...
More than 14 percent of the world’s population has had Lyme disease, the most common tick-borne illness, according to a major review of the available research...
Recent Comments